Updated Alzheimer disease diagnostic guidelines are expected to be released in the coming months. What aspects of this new clinical criteria are you most anticipating? Let us know with this latest poll. ...
Updated Alzheimer disease diagnostic guidelines are expected to be released in the coming months. What aspects of this new clinical criteria are you most anticipating? Let us know with this latest poll. ...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
Epilepsy is often genetic and can be passed on to children. Do you believe genetic testing has a role in epilepsy management? Take our poll to voice your opinion!
As the number of Americans with Alzheimer disease rises, researchers continue to look for reliable biomarkers for the disease. Do you think researchers will find one? Let us know by taking our poll.
Do you think the neurodegeneration that serves as the basis of the biomarker-based concept of suspected non-amyloid pathology can be considered a pre-clinical state of Alzheimer disease? Let us know by...
